Yale University-ko ikertzaileekin lankidetzan egindako argitalpenak (38)

2024

  1. Bacille Calmette-Guérin vaccination to prevent febrile and respiratory illness in adults (BRACE): secondary outcomes of a randomised controlled phase 3 trial

    eClinicalMedicine, Vol. 72

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Bacillus Calmette-Guérin vaccination for protection against recurrent herpes labialis: a nested randomised controlled trial

    eClinicalMedicine, Vol. 64

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

  3. Prenatal and postnatal exposure to acetaminophen in relation to autism spectrum and attention-deficit and hyperactivity symptoms in childhood: Meta-analysis in six European population-based cohorts

    European Journal of Epidemiology, Vol. 36, Núm. 10, pp. 993-1004

  4. Targeted therapies for extrahepatic cholangiocarcinoma: preclinical and clinical development and prospects for the clinic

    Expert Opinion on Investigational Drugs, Vol. 30, Núm. 4, pp. 377-388

  5. rs641738C>T near MBOAT7 is associated with liver fat, ALT and fibrosis in NAFLD: A meta-analysis

    Journal of Hepatology, Vol. 74, Núm. 1, pp. 20-30

2020

  1. Early life exposure to perfluoroalkyl substances (PFAS) and ADHD: A meta-analysis of nine European population-based studies

    Environmental Health Perspectives, Vol. 128, Núm. 5

  2. Mendelian randomization analysis of n-6 polyunsaturated fatty acid levels and pancreatic cancer risk

    Cancer Epidemiology Biomarkers and Prevention, Vol. 29, Núm. 12, pp. 2735-2739

  3. Type 3 Inositol 1,4,5-Trisphosphate Receptor Is Increased and Enhances Malignant Properties in Cholangiocarcinoma

    Hepatology, Vol. 71, Núm. 2, pp. 583-599

2019

  1. Pathobiology of inherited biliary diseases: a roadmap to understand acquired liver diseases

    Nature Reviews Gastroenterology and Hepatology, Vol. 16, Núm. 8, pp. 497-511

  2. The challenges of primary biliary cholangitis: What is new and what needs to be done

    Journal of Autoimmunity, Vol. 105

  3. The tumour microenvironment and immune milieu of cholangiocarcinoma

    Liver International, Vol. 39, Núm. S1, pp. 63-78

2018

  1. Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy

    PLoS ONE, Vol. 13, Núm. 9

2017

  1. Global, regional, and national age-sex specifc mortality for 264 causes of death, 1980-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1151-1210

  2. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: A systematic analysis for the Global Burden of Disease Study 2016

    The Lancet, Vol. 390, Núm. 10100, pp. 1084-1150

  3. Healthcare access and quality index based on mortality from causes amenable to personal health care in 195 countries and territories, 1990-2015: A novel analysis from the global burden of disease study 2015

    The Lancet, Vol. 390, Núm. 10091, pp. 231-266